🇺🇸US Compliance

Understanding MoCRA Responsible Person Requirements

Complete guide to MoCRA responsible person requirements. Learn who qualifies, duties, liability, and how to designate a responsible person for FDA compliance.

Verified January 16, 2026

Guide Information

Published by: Global Cosmetic Regs Editorial Team

Last updated: January 16, 2026

Verified against: 21 USC 364 Definitions

Sources: 3 official documents

View our methodology →

This guide is part of our comprehensive MoCRA FDA Guidelines: Complete Compliance Guide for 2026 resource.

What is a Responsible Person Under MoCRA?

Under the Modernization of Cosmetics Regulation Act (MoCRA), every cosmetic product distributed in the United States must have a designated responsible person. This is a legal requirement, not an optional best practice.

Core Concept

The responsible person is the entity legally accountable for the cosmetic product's compliance with MoCRA requirements. This includes safety substantiation, adverse event reporting, product listing, and labeling compliance.

The responsible person concept is similar to the EU's "responsible person" requirement under the Cosmetic Products Regulation, bringing US regulation more in line with global standards.

According to 21 U.S.C. § 364, the term "responsible person" means:

> "The manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 362(b)(1) or section 362(b)(2)."

In practical terms, this means the responsible person is determined by whose name and contact information appears on the product label.

Who Can Be a Responsible Person?

Responsible Person by Business Type
Business TypeCan Be RP?When They Are RP
Brand OwnerYesWhen brand name appears on label (most common)
Contract ManufacturerYesWhen they market under their own name
Private Label BrandYesWhen their name appears on label
Importer/DistributorYesWhen they market under their own name
Foreign Manufacturer (direct)Yes*Must have US Agent as contact
Retailer (own brands)YesFor private label/store brand products

* *Foreign companies can be the responsible person but must have a US Agent for FDA communications

Determining the Responsible Person

How to Determine the Responsible Person

1
Look at the Product Label

The responsible person is determined by whose name appears on the label in accordance with FDA labeling regulations. This is typically in the format 'Manufactured by [Company]' or 'Distributed by [Company]'.

2
Identify the Named Entity

If the label states 'Manufactured by XYZ Company' — XYZ Company is the responsible person. If it states 'Distributed by ABC Brand' — ABC Brand is the responsible person.

3
Consider Contract Manufacturing

For contract-manufactured products, the brand owner is typically the responsible person because their name appears on the label, even though they didn't physically manufacture the product.

4
Document the Relationship

If you use contract manufacturers or other partners, ensure contracts clearly define who is the responsible person and who handles specific MoCRA obligations.

Responsible Person Duties

Under MoCRA, the responsible person has several mandatory duties:

1. Product Listing

Per FDA product listing guidance, the responsible person must:

Product Listing Duties

  • List all cosmetic products through FDA's Cosmetics Direct portal
  • Provide complete ingredient lists for each product
  • Update listings within 60 days of any product changes
  • List new products within 120 days of market entry
  • Maintain current contact information for FDA communications

2. Adverse Event Reporting

According to FDA adverse event guidance, the responsible person must:

Adverse Event Reporting Duties

  • Maintain records of all adverse event reports received
  • Evaluate whether events qualify as 'serious adverse events'
  • Report serious adverse events to FDA within 15 business days
  • Submit follow-up information within 15 business days if received within 1 year
  • Provide contact information on product labels for consumer reports

Definition of "Serious Adverse Event" (21 U.S.C. § 364a):

  • Death
  • Life-threatening experience
  • Inpatient hospitalization
  • Persistent or significant disability/incapacity
  • Congenital anomaly or birth defect
  • Infection (MoCRA-specific addition)
  • Significant disfigurement (serious rashes, 2nd/3rd-degree burns, significant hair loss, persistent appearance alteration)
  • Medical/surgical intervention needed to prevent above outcomes

Contact Information Required

Under FDA labeling requirements, the responsible person's contact information (address, phone number, or electronic contact) must appear on the product label to allow consumers to report adverse events.

3. Safety Substantiation

Per 21 U.S.C. § 364d, the responsible person must:

Safety Substantiation Duties

  • Ensure adequate safety substantiation exists for each product
  • Maintain safety records supporting the substantiation
  • Make records available to FDA upon request or during inspection
  • Update substantiation when new safety information becomes available

Record Retention Requirements: | Record Type | Standard Business | Small Business Exempt | |-------------|-------------------|----------------------| | Safety substantiation records | Ongoing (no specified end date) | Ongoing | | Adverse event records | 6 years | 3 years |

4. Labeling Compliance

Under 21 U.S.C. § 362 and 21 CFR Part 701, the responsible person ensures:

  • Product labels are not false or misleading
  • All required information appears on labels (ingredients, warnings, etc.)
  • Fragrance allergen disclosure requirements are met (when effective; currently PENDING)
  • Contact information for adverse event reporting is included

5. Records Access

Under 21 U.S.C. § 364f, the responsible person must:

  • Maintain all required records
  • Provide records to FDA upon request
  • Make records available during FDA inspections
  • Retain records for specified periods

Liability Considerations

Legal Accountability

The responsible person bears legal accountability for MoCRA compliance. Failure to meet requirements can result in FDA enforcement action including warning letters, product seizure, or injunctions.

What the Responsible Person Is Liable For

Responsible Person Liability Areas
ObligationConsequence of FailureEnforcement
Product listingWarning letters, potential misbrandingFDA inspections, compliance actions
Adverse event reportingWarning letters, potential legal actionFDA compliance program
Safety substantiationProduct may be deemed adulteratedRecalls, injunctions
Labeling complianceMisbranding chargesWarning letters, seizure
Records maintenanceObstruction charges possibleFDA inspections

Limiting Liability Through Agreements

When working with contract manufacturers or other partners:

Contractual Protections

  • Define responsible person status clearly in supply agreements
  • Specify which party handles each MoCRA obligation
  • Include indemnification provisions for regulatory non-compliance
  • Require contract manufacturers to provide safety data and documentation
  • Establish communication protocols for adverse event information
  • Include audit rights to verify compliance

Requirements for International Brands

US Agent Requirement

Foreign companies whose products are sold in the US must designate a US Agent for FDA communications. Per FDA guidance:

US Agent vs. Responsible Person

The US Agent and Responsible Person are different concepts. The US Agent handles FDA communications for the foreign company. The Responsible Person is accountable for product compliance. A foreign company can be the responsible person but must have a US Agent for FDA contact purposes.

US Agent Duties

The US Agent must:

  • Reside in the United States or maintain a place of business in the US
  • Be available during normal business hours to respond to FDA inquiries
  • Assist FDA in scheduling inspections
  • If desired, submit registration and listing on behalf of the foreign facility

Options for Foreign Brands

Options for Foreign Companies
ApproachResponsible PersonUS AgentBest For
Foreign company as RPForeign companyRequired separatelyLarge brands with US operations
US distributor as RPUS distributorNot neededBrands working with US partners
US subsidiary as RPUS subsidiaryNot neededEstablished US presence
Service provider arrangementForeign companyService providerSmall brands entering US

Import Alerts

Per FDA import alert guidance, products from unregistered facilities or without proper responsible person designation may be subject to import detention without physical examination.

How to Designate a Responsible Person

Designating a Responsible Person

1
Determine Label Attribution

Decide whose name will appear on the product label. This entity will be the responsible person. Consider business structure, liability preferences, and operational capabilities.

2
Ensure Legal Capacity

The responsible person must be a legal entity capable of entering contracts and accepting regulatory obligations. This can be a corporation, LLC, partnership, or individual (for sole proprietors).

3
Establish Compliance Infrastructure

The responsible person needs systems to handle adverse event intake, product listing management, safety record maintenance, and FDA communications.

4
Register and List

Complete facility registration (if applicable) and product listing through FDA Cosmetics Direct, providing the responsible person's information.

5
Update Product Labels

Ensure all product labels include the responsible person's name and contact information for adverse event reporting.

6
Document the Designation

Maintain internal records documenting the responsible person designation, especially important when contract manufacturing is involved.

Record Keeping Requirements

Under 21 U.S.C. § 364f, the responsible person must maintain:

Record Keeping Requirements
Record TypeRetention PeriodFormat
Safety substantiationMarket period + 3 yearsAny format, English or translatable
Adverse event reports6 years minimumAny format, readily accessible
Product listing informationCurrent, updated within 60 daysElectronic via FDA portal
Labeling copiesMarket period + 3 yearsPhysical or electronic
Manufacturing recordsAs required by GMPPer FDA GMP guidance

Records Access

FDA has authority to access safety substantiation records during inspections or upon written request. Records must be provided in English or translated upon request.

Changing the Responsible Person

If the responsible person changes (e.g., due to acquisition or rebranding):

Steps When Changing Responsible Person

  • Update product listing in Cosmetics Direct within 60 days
  • Update product labels with new responsible person information
  • Transfer safety substantiation records to new responsible person
  • Transfer adverse event records and reporting history
  • Update internal systems and contact information
  • Notify FDA if the change affects facility registration
Every cosmetic product sold in the US must have a responsible person
The responsible person is determined by whose name appears on the product label
Key duties include product listing, adverse event reporting, and safety substantiation
Foreign companies can be the responsible person but must designate a US Agent
The responsible person bears legal accountability for MoCRA compliance
Clear contractual agreements are essential when working with manufacturing partners

Need Help with Responsible Person Requirements?

Our regulatory specialists can help you establish the right compliance structure for your cosmetic business.

Get Expert Help

Frequently Asked Questions

Sources & References
  1. U.S. Food and Drug Administration. "Modernization of Cosmetics Regulation Act of 2022 (MoCRA) Overview." (2023-12). fda.gov. Accessed 2026-01-12.
  2. U.S. Food and Drug Administration. "Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products." (2023-12). fda.gov. Accessed 2026-01-12.
  3. U.S. House of Representatives. "21 U.S.C. § 364 - Definitions (MoCRA)." (2025-01). uscode.house.gov. Accessed 2026-01-12.